Board of Directors

Gisela Sitbon (1958), Chairman

Board member since 2012,
Chairman since 2014

Education and training: Doctorate in medical sciences from the Karolinska Institute in Solna
Main experience: Twenty-five years’ experience in the life science industry, of which just over ten years in senior positions (including CEO) at Professional Genetics
Laboratory AB and five years as head of section at Karo Bio AB. Business coach in the life science sector at STING AB and responsible for business development for growth companies at her own company ZENZ AB.
Other board appointments: Board member and chairperson of Beactica AB and board member of Sitbon Bioscience Partner Zenz AB and Pharmacolog in Uppsala AB (publ.)
Holds 5,000 shares through the company Sitbon Bioscience Partner Zenz AB.

 

Peter von Ehrenheim (1955)

Board member since 2016

Education and training: Master of Science in Mechanical Engineering from Royal Institute of Technology (KTH), Stockholm.
Main experience: Head of the separation division at Amersham and GE Healthcare between 2000 and 2006, and CEO of GE Healthcare Life Sciences 2006 to 2011.
Other board appointments: Chairman of Biolin Scientific AB, Boule Diagnostics AB, VBN Components AB and Robustus Wear Components AB and board member of Biotage AB and Meda AB.
Holds 1,000 shares.

 

Hans Lennernäs (1960)

Board member since 2014

Education and training: Doctorate in pharmacy from Uppsala University
Main experience: Professor of Biopharmacy at the Department of Pharmacy, Uppsala University. Co-founder of, among others, DuoCort Pharma AB and LIDDS AB.
Other board appointments: Board member of Hans Lennernäs Biomedical AB, Recipharm Pharmaceutical Development AB and Empros Pharma AB

Holds 6,000 shares through the company Hans Lennernäs Biomedical AB.

 

Lena Torlegård (1963)

Board member since 2014

Education and training: B.Sc in business
administration from the Stockholm School of Economics
Main experience: Over 15 years’ experience as a communications consultant, for companies in the life science sector as well. She works primarily with financial communications and corporate communications but also with crisis management and trademark issues. Senior consultant at Springtime AB in Stockholm.
Other board appointments: Board member of Lytix Biopharma AS
Holds 2,500 shares.

 

Paula Zeilon (1962)

Board member since 2016

Education and training: Master of Science in
Chemical Engineering from the Faculty of Engineering (LTH) at Lund University.
Graduate Engineer Program, Stockholm School of Economics.
Main experience: Thirty years’ experience from the life science industry, of which 14 years within chromatography at Amersham Biosciences, in senior positions within product development and marketing. Paula is one of the founders of the consulting firm Conlega and has since 2000 been working with numerous life science companies with business development and interim management, among others as CEO at Life Science Foresight Institute, CEO at Alligator Bioscience, Director Marketing at Dako A/S, Director Marketing at Biotage and Director Business Development at Amersham.
Other board appointments: Board member of BioGaia AB.
Holds no shares in Nanologica.

 

Eva Byrod (1952)

Board Member since 2017

Education and training: Master of Science in Chemical Engineering Chalmers University of Technology
Main Experience: More than twenty-five years experience as a line manager in pharmaceutical research and development and ten years experience as a Project Manager/Project Director, working in early as well as late phase pharmaceutical development projects

Holds no shares in Nanologica.